Webinar With the recent publication of Ten years on: Measuring the Return from Pharmaceutical Innovation 2019, PharmaBoardroom has teamed up with Deloitte to offer its readers an exclusive webinar on The Future of Biopharma. On 25th February 2020, join us to discuss the major trends that have impacted the biopharma industry over the past ten years, the…
Puerto Rico Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to the island’s telecommunications, energy and water supply, the jewel in Puerto Rico’s crown – its pharmaceutical industry – remained largely…
Hungary Gergely Jánoki CEO of Medi-Radiopharma shares his insights on the activities of the company, the trends in the radiopharmaceutical industry while highlighting regulatory trends, the importance of quality, the driving factors behind the company’s success and his long-term vision of for the company. We grew more than 60 percent…
Czech Republic Kateřina Klancová, business unit manager at URGO Healthcare in the Czech Republic, shares the affiliate’s journey in aligning with the needs of today’s pharma market; discusses the opportunities and challenges of e-commerce and digital communications, and emphasizes their focus on bringing to market products based on innovative technologies with a…
Czech Republic Medicine shortages are a European-wide issue. In 2016, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) formed a task force to investigate availability issues, including medicines that are authorized but not marketed, and supply chain disruptions in order to improve the continuity of medicine supply across Europe. …
France France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that vaccines are safe, according to the Wellcome Global Monitor survey. However, the country is aiming to shed its reputation for vaccine hesitancy and roll out increased mandatory vaccinations for a…
USA David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference 2020 in San Francisco, noting a more subdued atmosphere than previous years, with reduced attendances and no big M&A announcements. Crean does, however, underline the importance of the Conference for industry networking and highlights some of the biopharma…
Pharma Legal Handbook A brief overview of the situation regarding biosimilars and biologics. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from The Pharma Legal Handbook: Algeria, available to purchase here for USD 99. 1. Are biosimilar medicines considered the same as generic medicines…
Pharma Legal Handbook The ins and outs of localization in Algeria. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from The Pharma Legal Handbook: Algeria, available to purchase here for USD 99. 1. Are there any rules or regulations requiring and/or encouraging localization in…
Pharma Legal Handbook A brief overview of the situation regarding orphan drugs and rare diseases in Algeria. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from The Pharma Legal Handbook: Algeria, available to purchase here for USD 99. 1. What is the definition of…
Pharma Legal Handbook Key legal info on cannabinoid drugs, medicinal cannabis and opioid drugs in Algeria. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from The Pharma Legal Handbook: Algeria, available to purchase here for USD 99. Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized…
Pharma Legal Handbook Regulatory reforms in Algerian Pharma – a comprehensive legal overview. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from The Pharma Legal Handbook: Algeria, available to purchase here for USD 99. 1. Are there proposals for reform or significant change to…
See our Cookie Privacy Policy Here